• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON ENDO-SURGERY, LLC. LIGAMAX-5MM ENDO CLIP APPLIER; CLIP, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON ENDO-SURGERY, LLC. LIGAMAX-5MM ENDO CLIP APPLIER; CLIP, IMPLANTABLE Back to Search Results
Model Number EL5ML
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
Patient Problems Wound Dehiscence (1154); Abscess (1690); Hematoma (1884); Hemorrhage/Bleeding (1888); Unspecified Infection (1930)
Event Date 08/01/2021
Event Type  Injury  
Manufacturer Narrative
(b)(4).Batch # unk.Date of event: date of publication is (b)(6) 2021.This report is related to a journal article; therefore, no product will be returned for analysis.The lot/batch was not provided; therefore, a manufacturing record evaluation could not be performed.Attempts are being made to obtain the following information: does the author/surgeon believe that the ethicon device caused or contributed to the patient complications mentioned in the article? if yes, please explain.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
It was reported that during a journal article review: title: uterine artery closure at the origin versus at the uterus level in total laparoscopic hysterectomy: a randomized controlled trial authors: stefano uccella, simone garzon, gabriele lanzo1, davide gallina, mariachiara bosco, irene porcari, salvatore gueli-alletti, stefano cianci, massimo franchi, pier carlo zorzato.Citation:acta obstet gynecol scand.2021;00:1¿9.Doi: 10.1111/aogs.14238 https://doi.Org/10.1111/aogs.14238.This study is a single-blind, parallel groups, two-arm, randomized controlled trial.The trial was conducted at the division of obstetrics and gynecology, department of maternal, neonatal and infant health, asl biella, biella, italy.Patient recruitment began on december 1, 2019 and ended on august 31, 2020.All surgeons perform hysterectomy using the same laparoscopic technique, which is standardized at the center in terms of instruments, steps, colpotomy, and colporrhaphy.A 30-day follow-up visit was performed for 172 patients (95.5%).The eight patients who did not attend the 30-day follow-up visit had a phone follow up.All 180 women were contacted by phone 4 months after surgery and completed the follow up.The ureter was visualized and followed along its course.With the opening of pararectal and paravesical spaces, the ua and its origin were identified and reached.The vessel was clipped just medially to its origin from the internal iliac artery using 5-mm titanium clips (ligamax¿5 endoscopic multiple clip applier,ethicon).Reported complications included intraoperative blood loss was higher in uterus level group (ul group) and bladder lesions , postoperative infection (n=3), vaginal cuff dehiscence (n=1), postoperative vaginal bleeding (n=3), vaginal evisceration (n=1), vaginal cuff hematoma/abscess(n=4) in conclusion the ua closure at the origin is superior to the closure at the ul in terms of lower intraoperative blood loss and higher reproducibility.However, the absence of translation into clinical benefits impedes the support of its clinical superiority in all cases.The routine uses of this approach may provide advantages in specific conditions, such as in the presence of severe preoperative anemia, deep infiltrating endometriosis, or ureteral duplication.Further studies should investigate whether ua closure at the origin reduces or increase complication rates, such as vaginal cuff complications, and further characterized clinical benefits.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIGAMAX-5MM ENDO CLIP APPLIER
Type of Device
CLIP, IMPLANTABLE
Manufacturer (Section D)
ETHICON ENDO-SURGERY, LLC.
475 calle c
guaynabo 00969
*  00969
Manufacturer (Section G)
ETHICON ENDO-SURGERY, LLC.
475 calle c
guaynabo
*  
Manufacturer Contact
kara ditty-bovard
475 calle c
guaynabo 
*  
6107428552
MDR Report Key12564446
MDR Text Key274421394
Report Number3005075853-2021-05874
Device Sequence Number1
Product Code FZP
UDI-Device Identifier10705036001843
UDI-Public10705036001843
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K050344
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 09/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberEL5ML
Device Catalogue NumberEL5ML
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/01/2021
Initial Date FDA Received10/01/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-